Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2003-12-01 / Hum. Cell 2003 Dec;16(4):175-82Overview of phase I studies of intravenous administration of PV701, an oncolytic virus
/in International Publications, Newcastle Disease Virus /von 2003-12-01 / Curr. Opin. Mol. Ther. 2003 Dec;5(6):618-24Dendritic cell-based immunotherapy in multiple myeloma
/in Dendritic Cells, International Publications, Malignant Lymphoma, Multiple Myeloma /von 2003-12-01 / Leuk. Lymphoma 2003 Dec;44(12):2031-8Clinical significance of immune cell infiltration within gallbladder cancer
/in Gallbladder Cancer, International Publications /von 2003-11-03 / Br. J. Cancer 2003 Nov;89(9):1736-42Whole body thermochemotherapy in an infant with rhabdomyosarcoma and pulmonary metastases
/in International Publications, NSCLC /von 2003-11-01 / Med. Pediatr. Oncol. 2003 Nov;41(5):478-80Immunobiology and gene-based immunotherapy of hepatocellular carcinoma
/in Hepatocellular Carcinoma, International Publications /von 2003-11-01 / Z Gastroenterol 2003 Nov;41(11):1101-10An approach for cure: PEI-chemotherapy and regional deep hyperthermia in children and adolescents with unresectable malignant tumors
/in Hyperthermia, International Publications, Soft Tissue Sarcoma /von 2003-11-01 / Klin Padiatr 2003 Nov-Dec;215(6):303-9Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patients
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2003-10-15 / J. Clin. Oncol. 2003 Oct;21(20):3826-35Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial
/in Dendritic Cells, Glioblastoma, International Publications /von 2003-10-06 / Br. J. Cancer 2003 Oct;89(7):1172-9
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de